Data from EMC - Curated by EPG Health - Last updated 01 November 2016

Indication(s)

Tavanic is indicated in adults for the treatment of the following infections:

- Acute bacterial sinusitis

- Acute exacerbations of chronic bronchitis

- Community-acquired pneumonia

- Complicated skin and soft tissue infections

For the above-mentioned infections Tavanic should be used only when it is considered inappropriate to use antibacterial agents that are commonly recommended for the initial treatment of these infections.

- Pyelonephritis and complicated urinary tract infections

- Chronic bacterial prostatitis

- Uncomplicated cystitis

- Inhalation Anthrax: post exposure prophylaxis and curative treatment

Tavanic may also be used to complete a course of therapy in patients who have shown improvement during initial treatment with intravenous levofloxacin.

Consideration should be given to official guidance on the appropriate use of antibacterial agents.

 

Full Prescribing information

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Sleep Apnea

Sleep Apnea

Sleep apnea is a chronic condition characterised by recurrent interruptions in breathing throughout the sleep cycle. Learn about the two main types of sleep apnea and hear from experts as they present the latest research at the Sleep and Breathing conference (Marseille, 2019).

Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease (COPD)

View highlights from recent congresses presented in new expert videos with leading physicians.

+ 7 more

Cystic Fibrosis Knowledge Centre

Cystic Fibrosis Knowledge Centre

View disease awareness information, treatment options and European Cystic Fibrosis Society best practice guidelines.

Load more

Related Content

Journal articles

Ceftolozane/tazobactam and ceftazidime/avibactam: two novel β-lactam/β-lactamase inhibitor combination agents for the treatment of resistant Gram-negative bacterial infections.

The rise in resistant Gram-negative bacteria is a major concern and has led to difficulty in treating multidrug-resistant (MDR) infections....

Added 3 years ago

Early Response in Cellulitis: A Prospective Study of Dynamics and Predictors.

Skin and soft tissue infections are common reasons for medical care. Use of broad-spectrum therapy and costs have increased. Assessment of early treatment response has been given a central role both in clinical trials and everyday practice. 

Added 2 years ago

Do surgical interventions for limb lymphoedema reduce cellulitis attack frequency?

Recurrent cellulitis is a frequent and challenging complication of lymphoedema.

Added 2 years ago

Load more

View all 13526 Journal articles items
Guidelines

2015 UK National Guideline on the management of non-gonococcal urethritis

We present the updated British Association for Sexual Health and HIV guideline for the management of non-gonococcal urethritis in men. This document includes a review of the current literature on its aetiology, diagnosis and management.

Added 4 years ago

United Kingdom National Guideline on the Management of Trichomonas vaginalis 2014

The main objective is to assist practitioners in managing men and women diagnosed with Trichomonas vaginalis. This guideline offers recommendations on the diagnostic tests, treatment regimens and health promotion principle...

Added 5 years ago

Management of genital Chlamydia trachomatis infection

This guideline covers chlamydial infection of the genital tract and rectum and provides recommendations on: laboratory tests; testing asymptomatic groups at risk of infection; testing for other sexually transmitted infections...

Added 10 years ago

Load more

View all 1465 Guidelines items

More information

Category Value
Orphan designation No
Type POM
Marketing authorisation holder Sanofi-aventis